What are the priorities for managing cholesterol effectively?
Many studies have confirmed the risk of coronary artery disease associated with elevated levels of low-density lipoprotein cholesterol (LDL-C). The precise role of other lipids, however, is still under investigation. The relation between elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol (HDL-C) is complex, and the results of clinical trials evaluating interventions to lower triglycerides or increase levels of HDL-C have been equivocal. Based on the data currently available, LDL-C remains the primary target for treatment. Ongoing clinical trials will help to answer the question of how low we should set our goals for lowering cholesterol in patients at risk.